title: What it takes to defend deceptive placebo use.
abstract: A complete defense of deceptive placebo use must address this ethical objection: deceptive placebo use violates patient autonomy, because deceiving a patient about the placebo nature of a proposed treatment prevents her from giving informed consent to the treatment. Unfortunately, this objection isn't always recognized and clearly disambiguated from other ethical concerns. I consider how well several bioethicists who write about placebo use have responded to, or evaded, this objection. I conclude that defenders of deceptive placebo use should, following the lead of Onora O'Neill, argue that deceptive placebo use is compatible with informed consent.
authors.affiliation: Johns Hopkins University, USA.
authors.forename: Anne
authors.initials: A
authors.lastname: Barnhill
mesh_terms: D018849:Controlled Clinical Trials as Topic / Q000941:ethics* / Q000379:methods*; D008192:Deception; D006801:Humans; D007258:Informed Consent / Q000941:ethics*; D028681:Moral Obligations; D028701:Patient Rights / Q000941:ethics; D026684:Personal Autonomy; D010919:Placebos; D035844:Researcher-Subject Relations / Q000941:ethics*; D055990:Therapeutic Misconception
chemical_list: D010919:Placebos